mandibular advancement devices:indications and predictors of treatment outcome

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

[automatically translated] Obstructive sleep apnea syndrome (OSAS) is a chronic sleep and respiratory disorder, Which causes a partial or total obstruction of the air passage at the upper airway level. Mandibular advancement devices (MADs) sono stati used in the treatment of snoring, but may be a valid alternative to the nasal continuous positive airway pressure (CPAP) for Certain OSAS cases. Therapy by means of MADs arises the interest of the scientific community and now there are many sleep-centers where dentists work as experts in sleep disorders. MADs are instruments of value Because They are simple to use, reversible, portable and Generally they have a low complication rate. They mechanically Increase the oropharyngeal space by advancing the mandible and / or the tongue and reduce pharyngeal collapsibility. More than 60 different MADs are in use, with considerable variations in design. Several studies show That Their systematic use Produces an evident improvement in the global quality of life as well as in the symptoms of patients with OSAS, especially sleepiness. Even though significant progress Has Been Made in proving the efficacy of MADs for OSAS, the ability to predict the outcome and treatment Hence pre-select suitable candidates for this treatment still remains in its early stage. The first aim of this review is to supply to the clinician informations on the cephalometric and polysomnographic parameters That can be used to predict the efficacy of the outcome of MAD therapy in OSAS. Moreover, we examine the cases for Which the use of MAD is indicato. Several studies show That Their systematic use Produces an evident improvement in the global quality of life as well as in the symptoms of patients with OSAS, especially sleepiness. Even though significant progress Has Been Made in proving the efficacy of MADs for OSAS, the ability to predict the outcome and treatment Hence pre-select suitable candidates for this treatment still remains in its early stage. The first aim of this review is to supply to the clinician informations on the cephalometric and polysomnographic parameters That can be used to predict the efficacy of the outcome of MAD therapy in OSAS. Moreover, we examine the cases for Which the use of MAD is indicato. Several studies show That Their systematic use Produces an evident improvement in the global quality of life as well as in the symptoms of patients with OSAS, especially sleepiness. Even though significant progress Has Been Made in proving the efficacy of MADs for OSAS, the ability to predict the outcome and treatment Hence pre-select suitable candidates for this treatment still remains in its early stage. The first aim of this review is to supply to the clinician informations on the cephalometric and polysomnographic parameters That can be used to predict the efficacy of the outcome of MAD therapy in OSAS. Moreover, we examine the cases for Which the use of MAD is indicato. the ability to predict the outcome and treatment Hence pre-select suitable candidates for this treatment still remains in its early stage. The first aim of this review is to supply to the clinician informations on the cephalometric and polysomnographic parameters That can be used to predict the efficacy of the outcome of MAD therapy in OSAS. Moreover, we examine the cases for Which the use of MAD is indicato. the ability to predict the outcome and treatment Hence pre-select suitable candidates for this treatment still remains in its early stage. The first aim of this review is to supply to the clinician informations on the cephalometric and polysomnographic parameters That can be used to predict the efficacy of the outcome of MAD therapy in OSAS. Moreover, we examine the cases for Which the use of MAD is indicato.
Original languageItalian
Pages (from-to)427-443
JournalMinerva Stomatologica
Volume56
Publication statusPublished - 2007

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{106bf904062f4b07a200ca1594a5f367,
title = "mandibular advancement devices:indications and predictors of treatment outcome",
abstract = "Obstructive sleep apnea syndrome (OSAS) is a chronic sleep and respiratory disorder, which causes a partial or total obstruction of the air passage at the upper airway level. Mandibular advancement devices (MADs) have been used in the treatment of snoring, but may be a valid alternative to the continuous nasal positive airway pressure (CPAP) for certain OSAS cases. Therapy by means of MADs arises the interest of the scientific community and now there are many sleep-centres where dentists work as experts in sleep disorders. MADs are instruments of value because they are simple to use, reversible, portable and they generally have a low complication rate. They mechanically increase the oropharyngeal space by advancing the mandible and/or the tongue and reduce pharyngeal collapsibility. More than 60 different MADs are in use, with considerable variations in design. Several studies show that their systematic use produces an evident improvement in the global quality of life as well as in the symptoms of patients with OSAS, especially sleepiness. Even though significant progress has been made in proving the efficacy of MADs for OSAS, the ability to predict the treatment outcome and hence pre-select suitable candidates for this treatment still remains in its early stage. The first aim of this review is to supply to the clinician informations on the cephalometric and polysomnographic parameters that can be used to predict the efficacy of the outcome of MAD therapy in OSAS. Moreover, we examine the cases for which the use of a MAD is indicated.",
author = "Carola Caradonna and Cuccia, {Antonino Marco}",
year = "2007",
language = "Italian",
volume = "56",
pages = "427--443",
journal = "Minerva Stomatologica",
issn = "0026-4970",
publisher = "Edizioni Minerva Medica S.p.A.",

}

TY - JOUR

T1 - mandibular advancement devices:indications and predictors of treatment outcome

AU - Caradonna, Carola

AU - Cuccia, Antonino Marco

PY - 2007

Y1 - 2007

N2 - Obstructive sleep apnea syndrome (OSAS) is a chronic sleep and respiratory disorder, which causes a partial or total obstruction of the air passage at the upper airway level. Mandibular advancement devices (MADs) have been used in the treatment of snoring, but may be a valid alternative to the continuous nasal positive airway pressure (CPAP) for certain OSAS cases. Therapy by means of MADs arises the interest of the scientific community and now there are many sleep-centres where dentists work as experts in sleep disorders. MADs are instruments of value because they are simple to use, reversible, portable and they generally have a low complication rate. They mechanically increase the oropharyngeal space by advancing the mandible and/or the tongue and reduce pharyngeal collapsibility. More than 60 different MADs are in use, with considerable variations in design. Several studies show that their systematic use produces an evident improvement in the global quality of life as well as in the symptoms of patients with OSAS, especially sleepiness. Even though significant progress has been made in proving the efficacy of MADs for OSAS, the ability to predict the treatment outcome and hence pre-select suitable candidates for this treatment still remains in its early stage. The first aim of this review is to supply to the clinician informations on the cephalometric and polysomnographic parameters that can be used to predict the efficacy of the outcome of MAD therapy in OSAS. Moreover, we examine the cases for which the use of a MAD is indicated.

AB - Obstructive sleep apnea syndrome (OSAS) is a chronic sleep and respiratory disorder, which causes a partial or total obstruction of the air passage at the upper airway level. Mandibular advancement devices (MADs) have been used in the treatment of snoring, but may be a valid alternative to the continuous nasal positive airway pressure (CPAP) for certain OSAS cases. Therapy by means of MADs arises the interest of the scientific community and now there are many sleep-centres where dentists work as experts in sleep disorders. MADs are instruments of value because they are simple to use, reversible, portable and they generally have a low complication rate. They mechanically increase the oropharyngeal space by advancing the mandible and/or the tongue and reduce pharyngeal collapsibility. More than 60 different MADs are in use, with considerable variations in design. Several studies show that their systematic use produces an evident improvement in the global quality of life as well as in the symptoms of patients with OSAS, especially sleepiness. Even though significant progress has been made in proving the efficacy of MADs for OSAS, the ability to predict the treatment outcome and hence pre-select suitable candidates for this treatment still remains in its early stage. The first aim of this review is to supply to the clinician informations on the cephalometric and polysomnographic parameters that can be used to predict the efficacy of the outcome of MAD therapy in OSAS. Moreover, we examine the cases for which the use of a MAD is indicated.

UR - http://hdl.handle.net/10447/25671

M3 - Article

VL - 56

SP - 427

EP - 443

JO - Minerva Stomatologica

JF - Minerva Stomatologica

SN - 0026-4970

ER -